Investors

Presentation

This section provides all the information and documents of interest to the financial community.

Shareholders’ space

Corporate
05/11/2026

Valbiotis poursuit son déploiement en Asie

Download
Corporate
04/23/2026

Valbiotis expands its e-commerce to Belgium and Luxembourg

Download
Corporate
04/17/2026

General Meeting of April 17, 2026 : All Resolutions Approved

Download
Corporate
03/19/2026

launch of operations in Asia

Download

Breakdown of share capital

Capital breakdown updated as of November, 27, 2025
62% of capital held by individual investors (Source: TPI, November, 27, 2025)

 

Analysts coverage

Portzamparc*
Analysts: Mohamed Kaabouni

Invest Securities*
Analyst: Thibaut Voglimacci-Stephanopoli

TP ICAP Midcap*
Analyst: Corentin Marty

Euroland Corporate*
Analyst : Valérie Dieppe

*Sponsored research

 

Financial calendar

 

Events
3
March 2025

Publication of Annual Financial Report

18
April 2025

Annual General Meeting

2
March 2026

Publication of annual results

12
October 2026

Publication of half-year results

Regulatory information

Access documents

Annual general meetings

Access documents

Shareholder Benefit

Terms and Conditions of the Valbiotis Shareholder Benefit

1. Purpose of the Shareholder Benefit

Valbiotis offers its shareholders a dedicated commercial benefit consisting of a 20% discount applicable to orders placed on the Valbiotis e‑commerce website accessible at the following URL: https://www.valbiotis.com/fr-fr/ (the “Website”), under the conditions set out below (the “Benefit”).
This Benefit does not constitute a dividend nor a financial right attached to the shares.

2. Eligible Beneficiaries

The Benefit is available to any Valbiotis shareholder who is a natural person holding at least eighty‑five (85) Valbiotis shares, whether registered or bearer shares, subject to the provision of valid proof of share ownership and compliance with these terms and conditions.

3. Access and Activation Process

Access to the Benefit is granted exclusively upon request by the shareholder, by contacting Valbiotis’ customer service at the following address: service-client@valbiotis.com, and providing the email address associated with their customer account on the Website.
The shareholder must provide proof of share ownership in their name and dated (for example: a recent bank certificate or a screenshot of the securities account serving as valid evidence).
Valbiotis reserves the right to request any additional supporting documents and to refuse activation of the Benefit if the proof provided is incomplete, illegible, non‑compliant, or manifestly insufficient.

4. Validity Period and Renewal

The Benefit is valid for a period of twelve (12) months from the date of activation by customer service.
At the end of this period, any shareholder wishing to continue benefiting from the Benefit must provide new proof of share ownership.
Failing this, the Benefit will be automatically deactivated.

5. Conditions of Use of the Discount

The discount granted under the Benefit amounts to 20%, with no minimum purchase requirement, and may be used exclusively on the Website.
It applies to the amount of the shopping cart excluding delivery charges and is valid for all orders within the limits of the countries serviced by the Website and subject to applicable logistical and regulatory constraints.
The Benefit may not be combined with other promotions, promotional codes, or current commercial offers and may not give rise to any refund, exchange, or financial compensation.

6. Personal and Non‑Transferable Nature

The Benefit is strictly personal, non‑transferable, and reserved for the exclusive use of the eligible shareholder.
Any fraudulent, abusive, or non‑compliant use in violation of these terms and conditions may result in the immediate cancellation of the Benefit without prior notice.

7. Personal Data (GDPR)

Personal data collected in connection with the management of the Benefit are processed by Valbiotis in accordance with applicable personal data protection regulations, in particular the General Data Protection Regulation (GDPR).
Such data are used exclusively to verify shareholder eligibility and to manage the Benefit.
Shareholders have the right to access, rectify, object to, and request deletion of their personal data under the conditions described in Valbiotis’ Privacy and Cookies Policy.

8. Modification or Termination of the Benefit

Valbiotis reserves the right to modify, suspend, or terminate the Benefit, in particular in the event of legal, regulatory, technical, or operational constraints.
Any modification or termination of the Benefit will not apply to Benefits already activated, which will continue to produce their effects until their expiry date, unless there is a legitimate reason making their continuation impossible.
Concerned shareholders will be informed of any changes via the Valbiotis investor website.